Cargando…

Post‐exposure prophylaxis for HIV infection in sexual assault victims

OBJECTIVES: Sexual assault (SA) is recognized as a public health problem of epidemic proportions. Guidelines recommend the administration of post‐exposure prophylaxis (PEP) after an SA. However, few data are available about the feasibility of this strategy, and this study was conducted to assess thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Inciarte, A, Leal, L, Masfarre, L, Gonzalez, E, Diaz‐Brito, V, Lucero, C, Garcia‐Pindado, J, León, A, García, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916272/
https://www.ncbi.nlm.nih.gov/pubmed/31603619
http://dx.doi.org/10.1111/hiv.12797
_version_ 1783480197762252800
author Inciarte, A
Leal, L
Masfarre, L
Gonzalez, E
Diaz‐Brito, V
Lucero, C
Garcia‐Pindado, J
León, A
García, F
author_facet Inciarte, A
Leal, L
Masfarre, L
Gonzalez, E
Diaz‐Brito, V
Lucero, C
Garcia‐Pindado, J
León, A
García, F
author_sort Inciarte, A
collection PubMed
description OBJECTIVES: Sexual assault (SA) is recognized as a public health problem of epidemic proportions. Guidelines recommend the administration of post‐exposure prophylaxis (PEP) after an SA. However, few data are available about the feasibility of this strategy, and this study was conducted to assess this. METHODS: We conducted a retrospective, longitudinal, observational study in SA victims attending the Hospital Clinic in Barcelona from 2006 to 2015. A total of 1695 SA victims attended the emergency room (ER), of whom 883 met the PEP criteria. Five follow‐up visits were scheduled at days 1, 10, 28, 90 and 180 in the out‐patient clinic. The primary endpoint was PEP completion rate at day 28. Secondary endpoints were loss to follow‐up, treatment discontinuation, occurrence of adverse events (AEs) and rate of seroconversion. RESULTS: The median age of participants was 25 years [interquartile range (IQR) 21–33 years] and 93% were female. The median interval between exposure and presentation at the ER was 13 h (IQR 6–24 h). The level of risk was appreciable in 47% (n = 466) of individuals. Of 883 patients receiving PEP, 631 lived in Catalonia. In this group, the PEP completion rate at day 28 was 29% (n = 183). The follow‐up rate was 63% (n = 400) and 38% (n = 241) at days 1 and 28, respectively. Treatment discontinuation was present in 58 (15%) of 400 patients who attended at least the day 1 visit, the main reason being AEs (n = 35; 60%). AEs were reported in 226 (56%) patients, and were mainly gastrointestinal (n = 196; 49%). Only 211 (33%) patients returned for HIV testing at day 90. A single seroconversion was observed in a men who have sex with men (MSM) patient at day 120. CONCLUSIONS: Follow‐up and compliance rates in SA victims were poor. In addition, > 50% of the patients experienced AEs, which were the main reason for PEP interruption. Strategies to increase follow‐up testing and new better tolerated drug regimens must be investigated to address these issues.
format Online
Article
Text
id pubmed-6916272
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69162722019-12-17 Post‐exposure prophylaxis for HIV infection in sexual assault victims Inciarte, A Leal, L Masfarre, L Gonzalez, E Diaz‐Brito, V Lucero, C Garcia‐Pindado, J León, A García, F HIV Med Original Research OBJECTIVES: Sexual assault (SA) is recognized as a public health problem of epidemic proportions. Guidelines recommend the administration of post‐exposure prophylaxis (PEP) after an SA. However, few data are available about the feasibility of this strategy, and this study was conducted to assess this. METHODS: We conducted a retrospective, longitudinal, observational study in SA victims attending the Hospital Clinic in Barcelona from 2006 to 2015. A total of 1695 SA victims attended the emergency room (ER), of whom 883 met the PEP criteria. Five follow‐up visits were scheduled at days 1, 10, 28, 90 and 180 in the out‐patient clinic. The primary endpoint was PEP completion rate at day 28. Secondary endpoints were loss to follow‐up, treatment discontinuation, occurrence of adverse events (AEs) and rate of seroconversion. RESULTS: The median age of participants was 25 years [interquartile range (IQR) 21–33 years] and 93% were female. The median interval between exposure and presentation at the ER was 13 h (IQR 6–24 h). The level of risk was appreciable in 47% (n = 466) of individuals. Of 883 patients receiving PEP, 631 lived in Catalonia. In this group, the PEP completion rate at day 28 was 29% (n = 183). The follow‐up rate was 63% (n = 400) and 38% (n = 241) at days 1 and 28, respectively. Treatment discontinuation was present in 58 (15%) of 400 patients who attended at least the day 1 visit, the main reason being AEs (n = 35; 60%). AEs were reported in 226 (56%) patients, and were mainly gastrointestinal (n = 196; 49%). Only 211 (33%) patients returned for HIV testing at day 90. A single seroconversion was observed in a men who have sex with men (MSM) patient at day 120. CONCLUSIONS: Follow‐up and compliance rates in SA victims were poor. In addition, > 50% of the patients experienced AEs, which were the main reason for PEP interruption. Strategies to increase follow‐up testing and new better tolerated drug regimens must be investigated to address these issues. John Wiley and Sons Inc. 2019-10-11 2020-01 /pmc/articles/PMC6916272/ /pubmed/31603619 http://dx.doi.org/10.1111/hiv.12797 Text en © 2019 The Authors. HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
Inciarte, A
Leal, L
Masfarre, L
Gonzalez, E
Diaz‐Brito, V
Lucero, C
Garcia‐Pindado, J
León, A
García, F
Post‐exposure prophylaxis for HIV infection in sexual assault victims
title Post‐exposure prophylaxis for HIV infection in sexual assault victims
title_full Post‐exposure prophylaxis for HIV infection in sexual assault victims
title_fullStr Post‐exposure prophylaxis for HIV infection in sexual assault victims
title_full_unstemmed Post‐exposure prophylaxis for HIV infection in sexual assault victims
title_short Post‐exposure prophylaxis for HIV infection in sexual assault victims
title_sort post‐exposure prophylaxis for hiv infection in sexual assault victims
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6916272/
https://www.ncbi.nlm.nih.gov/pubmed/31603619
http://dx.doi.org/10.1111/hiv.12797
work_keys_str_mv AT inciartea postexposureprophylaxisforhivinfectioninsexualassaultvictims
AT leall postexposureprophylaxisforhivinfectioninsexualassaultvictims
AT masfarrel postexposureprophylaxisforhivinfectioninsexualassaultvictims
AT gonzaleze postexposureprophylaxisforhivinfectioninsexualassaultvictims
AT diazbritov postexposureprophylaxisforhivinfectioninsexualassaultvictims
AT luceroc postexposureprophylaxisforhivinfectioninsexualassaultvictims
AT garciapindadoj postexposureprophylaxisforhivinfectioninsexualassaultvictims
AT leona postexposureprophylaxisforhivinfectioninsexualassaultvictims
AT garciaf postexposureprophylaxisforhivinfectioninsexualassaultvictims
AT postexposureprophylaxisforhivinfectioninsexualassaultvictims